Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors
Open Access
- 1 December 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 31 (23) , 6852-6859
- https://doi.org/10.1093/nar/gkg881
Abstract
Human immunodeficiency virus (HIV) RNase H activity is essential for the synthesis of viral DNA by HIV reverse transcriptase (HIV‐RT). RNA cleavage by RNase H requires the presence of divalent metal ions, but the role of metal ions in the mechanism of RNA cleavage has not been resolved. We measured HIV RNase H activity associated with HIV‐RT protein in the presence of different concentrations of either Mg2+, Mn2+, Co2+ or a combination of these divalent metal ions. Polymerase‐independent HIV RNase H was similar to or more active with Mn2+ and Co2+ compared with Mg2+. Activation of RNase H by these metal ions followed sigmoidal dose–response curves suggesting cooperative metal ion binding. Titration of Mg2+‐bound HIV RNase H with Mn2+ or Co2+ ions generated bell‐shaped activity dose–response curves. Higher activity could be achieved through simultaneous binding of more than one divalent metal ion at intermediate Mn2+ and Co2+ concentrations, and complete replacement of Mg2+ occurred at higher Mn2+ or Co2+ concentrations. These results are consistent with a two‐metal ion mechanism of RNA cleavage as previously suggested for a number of polymerase‐associated nucleases. In contrast, the structurally highly homologous RNase HI from Escherichia coli is most strongly activated by Mg2+, is significantly inhibited by submillimolar concentrations of Mn2+ and most probably cleaves RNA via a one‐metal ion mechanism. Based on this difference in active site structure, a series of small molecule N‐hydroxyimides was identified with significant enzyme inhibitory potency and selectivity for HIV RNase H.Keywords
This publication has 29 references indexed in Scilit:
- Unified two-metal mechanism of RNA synthesis and degradation by RNA polymeraseThe EMBO Journal, 2003
- Use of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease InhibitorsJournal of Medicinal Chemistry, 2003
- Inhibition of HIV-1 Ribonuclease H by a Novel Diketo Acid, 4-[5-(Benzoylamino)thien-2-yl]-2,4-dioxobutanoic AcidJournal of Biological Chemistry, 2003
- Helix Structure and Ends of RNA/DNA Hybrids Direct the Cleavage Specificity of HIV-1 Reverse Transcriptase RNase HJournal of Biological Chemistry, 1996
- Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compoundsAntimicrobial Agents and Chemotherapy, 1994
- Crystal structure of Escherichia coli RNase HI in complex with Mg2+ at 2.8 Å resolution: Proof for a single Mg2+‐binding siteProteins-Structure Function and Bioinformatics, 1993
- Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.Proceedings of the National Academy of Sciences, 1992
- Binding of metal ions toE. coli RNase HI observed by1H−15N heteronuclear 2D NMRJournal of Biomolecular NMR, 1991
- Mutations within the RNase H Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Abolish Virus InfectivityJournal of General Virology, 1991
- Interaction of HIV-1 ribonuclease H with polypurine tract containing RNA-DNA hybridsBiochemistry, 1990